The early kinetics of gentamicin uptake into the inner ear

Michael E Hoffer, Keith Allen, Kim Gottshall, Robert Moore, Richard D. Kopke, Derin Wester, Carey Balaban

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Transtympanic gentamicin administration has become a popular modality in the treatment of Ménière's disease. This modality and other inner-ear medical therapy are gaining increased clinical and scientific attention. We previously described the kinetics and effects of gentamicin uptake into the inner ear after delivery of the medicine into the middle ear using a variety of different techniques and sustained-release modalities [1]. In our previous work, we reported an early peak perilymph concentration and the presence of intracellular gentamicin at the 4-hour time point. We also demonstrated the activation of inner-ear damage pathways at this early time point. In this report, we examine the kinetics of gentamicin at very early time points, 1 and 2 hours after administration. Healthy adult chinchillas underwent implantation of middle-ear sustained-release devices (one to each ear) containing gentamicin. The animals then were maintained in a neutral position and underwent perilymph gentamicin sampling at the two predetermined time points. This technique allowed us to assess accurately very early time point inner-ear gentamicin kinetics and to compare the activity. The samples then were run for concentration using mass spectrometry. The information gained from this study may increase our scientific understanding about the effects of gentamicin on the inner ear and may allow clinicians to treat patients more effectively for inner-ear disorders.

Original languageEnglish (US)
Pages (from-to)27-29
Number of pages3
JournalInternational Tinnitus Journal
Volume8
Issue number1
StatePublished - 2002
Externally publishedYes

Fingerprint

Inner Ear
Gentamicins
Perilymph
Middle Ear
Chinchilla
Ear
Mass Spectrometry
Medicine
Equipment and Supplies
Therapeutics

Keywords

  • Fluorescent polar immunoassay
  • Gentamicin
  • Mass spectrometry
  • Ménière's disease
  • Sustained-release

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Hoffer, M. E., Allen, K., Gottshall, K., Moore, R., Kopke, R. D., Wester, D., & Balaban, C. (2002). The early kinetics of gentamicin uptake into the inner ear. International Tinnitus Journal, 8(1), 27-29.

The early kinetics of gentamicin uptake into the inner ear. / Hoffer, Michael E; Allen, Keith; Gottshall, Kim; Moore, Robert; Kopke, Richard D.; Wester, Derin; Balaban, Carey.

In: International Tinnitus Journal, Vol. 8, No. 1, 2002, p. 27-29.

Research output: Contribution to journalArticle

Hoffer, ME, Allen, K, Gottshall, K, Moore, R, Kopke, RD, Wester, D & Balaban, C 2002, 'The early kinetics of gentamicin uptake into the inner ear', International Tinnitus Journal, vol. 8, no. 1, pp. 27-29.
Hoffer ME, Allen K, Gottshall K, Moore R, Kopke RD, Wester D et al. The early kinetics of gentamicin uptake into the inner ear. International Tinnitus Journal. 2002;8(1):27-29.
Hoffer, Michael E ; Allen, Keith ; Gottshall, Kim ; Moore, Robert ; Kopke, Richard D. ; Wester, Derin ; Balaban, Carey. / The early kinetics of gentamicin uptake into the inner ear. In: International Tinnitus Journal. 2002 ; Vol. 8, No. 1. pp. 27-29.
@article{980b8e25236143e9864533ae8e5802c6,
title = "The early kinetics of gentamicin uptake into the inner ear",
abstract = "Transtympanic gentamicin administration has become a popular modality in the treatment of M{\'e}ni{\`e}re's disease. This modality and other inner-ear medical therapy are gaining increased clinical and scientific attention. We previously described the kinetics and effects of gentamicin uptake into the inner ear after delivery of the medicine into the middle ear using a variety of different techniques and sustained-release modalities [1]. In our previous work, we reported an early peak perilymph concentration and the presence of intracellular gentamicin at the 4-hour time point. We also demonstrated the activation of inner-ear damage pathways at this early time point. In this report, we examine the kinetics of gentamicin at very early time points, 1 and 2 hours after administration. Healthy adult chinchillas underwent implantation of middle-ear sustained-release devices (one to each ear) containing gentamicin. The animals then were maintained in a neutral position and underwent perilymph gentamicin sampling at the two predetermined time points. This technique allowed us to assess accurately very early time point inner-ear gentamicin kinetics and to compare the activity. The samples then were run for concentration using mass spectrometry. The information gained from this study may increase our scientific understanding about the effects of gentamicin on the inner ear and may allow clinicians to treat patients more effectively for inner-ear disorders.",
keywords = "Fluorescent polar immunoassay, Gentamicin, Mass spectrometry, M{\'e}ni{\`e}re's disease, Sustained-release",
author = "Hoffer, {Michael E} and Keith Allen and Kim Gottshall and Robert Moore and Kopke, {Richard D.} and Derin Wester and Carey Balaban",
year = "2002",
language = "English (US)",
volume = "8",
pages = "27--29",
journal = "International Tinnitus Journal",
issn = "0946-5448",
publisher = "Tinnitus Center",
number = "1",

}

TY - JOUR

T1 - The early kinetics of gentamicin uptake into the inner ear

AU - Hoffer, Michael E

AU - Allen, Keith

AU - Gottshall, Kim

AU - Moore, Robert

AU - Kopke, Richard D.

AU - Wester, Derin

AU - Balaban, Carey

PY - 2002

Y1 - 2002

N2 - Transtympanic gentamicin administration has become a popular modality in the treatment of Ménière's disease. This modality and other inner-ear medical therapy are gaining increased clinical and scientific attention. We previously described the kinetics and effects of gentamicin uptake into the inner ear after delivery of the medicine into the middle ear using a variety of different techniques and sustained-release modalities [1]. In our previous work, we reported an early peak perilymph concentration and the presence of intracellular gentamicin at the 4-hour time point. We also demonstrated the activation of inner-ear damage pathways at this early time point. In this report, we examine the kinetics of gentamicin at very early time points, 1 and 2 hours after administration. Healthy adult chinchillas underwent implantation of middle-ear sustained-release devices (one to each ear) containing gentamicin. The animals then were maintained in a neutral position and underwent perilymph gentamicin sampling at the two predetermined time points. This technique allowed us to assess accurately very early time point inner-ear gentamicin kinetics and to compare the activity. The samples then were run for concentration using mass spectrometry. The information gained from this study may increase our scientific understanding about the effects of gentamicin on the inner ear and may allow clinicians to treat patients more effectively for inner-ear disorders.

AB - Transtympanic gentamicin administration has become a popular modality in the treatment of Ménière's disease. This modality and other inner-ear medical therapy are gaining increased clinical and scientific attention. We previously described the kinetics and effects of gentamicin uptake into the inner ear after delivery of the medicine into the middle ear using a variety of different techniques and sustained-release modalities [1]. In our previous work, we reported an early peak perilymph concentration and the presence of intracellular gentamicin at the 4-hour time point. We also demonstrated the activation of inner-ear damage pathways at this early time point. In this report, we examine the kinetics of gentamicin at very early time points, 1 and 2 hours after administration. Healthy adult chinchillas underwent implantation of middle-ear sustained-release devices (one to each ear) containing gentamicin. The animals then were maintained in a neutral position and underwent perilymph gentamicin sampling at the two predetermined time points. This technique allowed us to assess accurately very early time point inner-ear gentamicin kinetics and to compare the activity. The samples then were run for concentration using mass spectrometry. The information gained from this study may increase our scientific understanding about the effects of gentamicin on the inner ear and may allow clinicians to treat patients more effectively for inner-ear disorders.

KW - Fluorescent polar immunoassay

KW - Gentamicin

KW - Mass spectrometry

KW - Ménière's disease

KW - Sustained-release

UR - http://www.scopus.com/inward/record.url?scp=0036289112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036289112&partnerID=8YFLogxK

M3 - Article

C2 - 14763232

AN - SCOPUS:0036289112

VL - 8

SP - 27

EP - 29

JO - International Tinnitus Journal

JF - International Tinnitus Journal

SN - 0946-5448

IS - 1

ER -